vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Mistras Group, Inc. (MG). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $181.5M, roughly 1.5× Mistras Group, Inc.). Mistras Group, Inc. runs the higher net margin — 2.1% vs 0.7%, a 1.4% gap on every dollar of revenue. On growth, Mistras Group, Inc. posted the faster year-over-year revenue change (5.1% vs -16.5%). Mistras Group, Inc. produced more free cash flow last quarter ($26.0M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Mistras Group, Inc. is a global provider of asset integrity and protection solutions, offering non-destructive testing, inspection, real-time monitoring, and engineering consulting services. Its key client segments include oil and gas, aerospace, power generation, and manufacturing industries, with operations spanning North America, Europe, and Asia-Pacific, helping clients enhance operational safety, extend asset lifespans, and minimize unplanned downtime.
HCM vs MG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $181.5M |
| Net Profit | $2.0M | $3.8M |
| Gross Margin | 37.7% | 28.4% |
| Operating Margin | -13.2% | 7.0% |
| Net Margin | 0.7% | 2.1% |
| Revenue YoY | -16.5% | 5.1% |
| Net Profit YoY | -83.6% | -27.4% |
| EPS (diluted) | $0.00 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $181.5M | ||
| Q3 25 | — | $195.5M | ||
| Q2 25 | $277.7M | $185.4M | ||
| Q1 25 | $324.5M | $161.6M | ||
| Q4 24 | — | $172.7M | ||
| Q3 24 | — | $182.7M | ||
| Q2 24 | $305.7M | $189.8M | ||
| Q1 24 | — | $184.4M |
| Q4 25 | $2.0M | $3.8M | ||
| Q3 25 | — | $13.1M | ||
| Q2 25 | $455.0M | $3.0M | ||
| Q1 25 | $11.9M | $-3.2M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | $25.8M | $6.4M | ||
| Q1 24 | — | $995.0K |
| Q4 25 | 37.7% | 28.4% | ||
| Q3 25 | — | 29.8% | ||
| Q2 25 | 0.1% | 29.1% | ||
| Q1 25 | 48.0% | 25.3% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | — | 26.8% | ||
| Q2 24 | 41.1% | 27.1% | ||
| Q1 24 | — | 25.0% |
| Q4 25 | -13.2% | 7.0% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | -1.3% | 4.5% | ||
| Q1 25 | -5.0% | -0.6% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 6.5% | ||
| Q2 24 | -9.0% | 6.3% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 0.7% | 2.1% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | 163.8% | 1.6% | ||
| Q1 25 | 3.7% | -2.0% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | 8.4% | 3.4% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | $0.00 | $0.12 | ||
| Q3 25 | — | $0.41 | ||
| Q2 25 | $0.52 | $0.10 | ||
| Q1 25 | $0.01 | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | — | $0.20 | ||
| Q2 24 | $0.03 | $0.20 | ||
| Q1 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $28.0M |
| Total DebtLower is stronger | $93.2M | $178.0M |
| Stockholders' EquityBook value | $1.2B | $235.1M |
| Total Assets | $1.8B | $578.8M |
| Debt / EquityLower = less leverage | 0.08× | 0.76× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $28.0M | ||
| Q3 25 | — | $27.8M | ||
| Q2 25 | $1.4B | $20.0M | ||
| Q1 25 | $836.1M | $18.5M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | $20.4M | ||
| Q2 24 | $802.5M | $17.2M | ||
| Q1 24 | — | $16.9M |
| Q4 25 | $93.2M | $178.0M | ||
| Q3 25 | — | $202.3M | ||
| Q2 25 | $93.4M | $189.4M | ||
| Q1 25 | $82.8M | $171.9M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $189.7M | ||
| Q2 24 | $82.1M | $199.7M | ||
| Q1 24 | — | $198.4M |
| Q4 25 | $1.2B | $235.1M | ||
| Q3 25 | — | $227.4M | ||
| Q2 25 | $1.2B | $215.8M | ||
| Q1 25 | $759.9M | $198.7M | ||
| Q4 24 | — | $198.6M | ||
| Q3 24 | — | $205.2M | ||
| Q2 24 | $740.1M | $193.2M | ||
| Q1 24 | — | $187.1M |
| Q4 25 | $1.8B | $578.8M | ||
| Q3 25 | — | $596.3M | ||
| Q2 25 | $1.8B | $571.0M | ||
| Q1 25 | $1.3B | $526.8M | ||
| Q4 24 | — | $523.0M | ||
| Q3 24 | — | $551.7M | ||
| Q2 24 | $1.3B | $548.1M | ||
| Q1 24 | — | $542.1M |
| Q4 25 | 0.08× | 0.76× | ||
| Q3 25 | — | 0.89× | ||
| Q2 25 | 0.08× | 0.88× | ||
| Q1 25 | 0.11× | 0.87× | ||
| Q4 24 | — | 0.85× | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | 0.11× | 1.03× | ||
| Q1 24 | — | 1.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $32.1M |
| Free Cash FlowOCF − Capex | $3.4M | $26.0M |
| FCF MarginFCF / Revenue | 1.2% | 14.3% |
| Capex IntensityCapex / Revenue | 1.8% | 3.4% |
| Cash ConversionOCF / Net Profit | 4.21× | 8.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $8.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $32.1M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | $-72.9M | $-9.3M | ||
| Q1 25 | $40.3M | $5.6M | ||
| Q4 24 | — | $25.7M | ||
| Q3 24 | — | $19.4M | ||
| Q2 24 | $-39.8M | $4.5M | ||
| Q1 24 | — | $604.0K |
| Q4 25 | $3.4M | $26.0M | ||
| Q3 25 | — | $-4.1M | ||
| Q2 25 | $-82.2M | $-14.7M | ||
| Q1 25 | $32.5M | $1.1M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | — | $14.6M | ||
| Q2 24 | $-49.9M | $-284.0K | ||
| Q1 24 | — | $-4.2M |
| Q4 25 | 1.2% | 14.3% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | -29.6% | -7.9% | ||
| Q1 25 | 10.0% | 0.7% | ||
| Q4 24 | — | 12.8% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | -16.3% | -0.1% | ||
| Q1 24 | — | -2.3% |
| Q4 25 | 1.8% | 3.4% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | 3.3% | 2.9% | ||
| Q1 25 | 2.4% | 2.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | 3.3% | 2.5% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | 4.21× | 8.55× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | -0.16× | -3.07× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 4.96× | ||
| Q3 24 | — | 3.02× | ||
| Q2 24 | -1.54× | 0.71× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
